DDW Editor Reece Armstrong speaks to Dr Carina Kern, Chief Executive Officer and Chief Scientific Officer, and Serena Kern-Libera, Chief Operating Officer, at LinkGevity about the company’s approach to tackling age-related diseases. RA: Could you tell us about LinkGevity’s approach to developing broad-spectrum therapeutics in the field of ageing? SK & CK: LinkGevity’s research shows […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!